top of page
Search


Cystitis and AMR. A critical analysis in <300 words,
UroPharma produced #intravesical drug-delivery technology to bring, under licence, better cystitis (lower #UTI) treatments. For decades,...

Scott Glickman
Apr 24, 20241 min read
0 views
0 comments


UroPharma is moving rapidly to commercialisation. The science and momentum are with us.
We are now moving into the MANUFACTURING STAGE, going through the pre-launch regulatory processes and distributors have been identified....

Gabriel Korn
Apr 20, 20231 min read
54 views
0 comments


New opportunities in bladder treatments.
As part of UroPharma’s development, Urinary Tract Infections are a main focal point. We are please to post our joint collaboration...

Gabriel Korn
Mar 10, 20231 min read
32 views
0 comments


New Bladder therapies to ease the suffering of millions by simply changing clinical practice.
UroPharma’s dtb-Instilla Intermittent will: aid the fight against anti-microbial resistance, Urinary Tract Infections and address the...

Gabriel Korn
Feb 7, 20232 min read
40 views
0 comments


Benefits of Direct-to-Bladder drug targeting.
Quality of Life is a priority for healthcare professionals. Direct-to-Bladder therapies by UroPharma go a long way towards achieving best...

Gabriel Korn
Nov 25, 20221 min read
11 views
0 comments


Direct to Bladder Therapies
About UroPharma UroPharma has patented and developed the world’s first licensed ‘direct to bladder’ drug delivery system, that will be in...

Gabriel Korn
Aug 12, 20221 min read
26 views
0 comments
bottom of page